Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Equity-to-Asset : -8.26 (As of Nov. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cannabis Bioscience International Holdings's Total Stockholders Equity for the quarter that ended in Nov. 2023 was $-0.84 Mil. Cannabis Bioscience International Holdings's Total Assets for the quarter that ended in Nov. 2023 was $0.10 Mil. Therefore, Cannabis Bioscience International Holdings's Equity to Asset Ratio for the quarter that ended in Nov. 2023 was -8.26.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Equity-to-Asset or its related term are showing as below:

CBIH' s Equity-to-Asset Range Over the Past 10 Years
Min: -8.26 Med: -8.26 Max: -8.26
Current: -8.26

During the past 5 years, the highest Equity to Asset Ratio of Cannabis Bioscience International Holdings was -8.26. The lowest was -8.26. And the median was -8.26.

CBIH's Equity-to-Asset is ranked worse than
97.79% of 1088 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs CBIH: -8.26

Cannabis Bioscience International Holdings Equity-to-Asset Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Equity-to-Asset Chart

Cannabis Bioscience International Holdings Annual Data

Trend

Dec06

Dec07

May09

May10

May11

Equity-to-Asset

-0.79

0.17

0.60

0.67

Cannabis Bioscience International Holdings Semi-Annual Data
	Dec06	Jun07	Dec07	Jun08	May09	Nov09	May10	Nov10	May11	Nov11	Nov22	Nov23
Equity-to-Asset	Get a 7-Day Free Trial							0.67	0.67	0.63	-	-8.26

Competitive Comparison of Cannabis Bioscience International Holdings's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Equity-to-Asset falls into.

Cannabis Bioscience International Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cannabis Bioscience International Holdings's Equity to Asset Ratio for the fiscal year that ended in May. 2011 is calculated as

Equity to Asset (A: May. 2011 )	=	Total Stockholders Equity	/	Total Assets
	=	62.165	/	93.043
	=	0.67

Cannabis Bioscience International Holdings's Equity to Asset Ratio for the quarter that ended in Nov. 2023 is calculated as

Equity to Asset (Q: Nov. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-0.842	/	0.102
	=	-8.25

Cannabis Bioscience International Holdings (OTCPK:CBIH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Cannabis Bioscience International Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabis Bioscience International Holdings (Cannabis Bioscience International Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 466S, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc is engaged in providing educational systems relating to cannabis and services in therapeutic areas. of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. The Company generates revenue from multiple streams, namely, clinical trials, consulting fees, video courses, seminars, royalties, and merchandise sales. The company generates the majority of its revenue from clinical trials.